Table 4.
GVHD preinfusion and postinfusion
| Patient ID no. | Prior GVHD | Baseline | GVHD Rx/PPx at infusion | aGVHD | cGVHD |
|---|---|---|---|---|---|
| 3910 | None | None | Cyclosporine | None | None |
| 3944 | None | None | Tacrolimus | None | None |
| 3976 | None | None | Tacrolimus | None | None |
| 3762 | None | None | None | None | None |
| 3967 | GI grade II | None | Sirolimus | None | None |
| 4091 | GI, skin grade II | None | Tacrolimus | None | None |
| 4115 | None | None | None | None | None |
| 4170 | None | None | Tacrolimus | None | None |
| 4134 | GI grade III | None | None | None | None |
| 4201 | None | None | Tacrolimus | None | None |
aGVHD, acute GVHD; cGVHD, chronic GVHD; GI, gastrointestinal; PPx, prophylaxis; Rx, treatment.